OLIN vs Solstice Advanced Materials
OLN and SOLS side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OLN and SOLS compare
Solstice Advanced Materials is the larger company, worth 4.8 times as much as OLIN ($9.6B against $2.0B).
Solstice Advanced Materials grew revenue faster over the last twelve months (9.2% versus −0.73% for OLIN).
Solstice Advanced Materials keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with −3.3% at OLIN.
Both pay dividends: OLIN yields 4.5% and Solstice Advanced Materials 0.37%.
OLIN scores higher on the StockData Score (11 against 7 for Solstice Advanced Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OLN | SOLS |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $9.6B |
| Share price | $17.60 | $60.55 |
| Change, 1 year | −17.7% | 22.9% |
| Change, 5 years | −71.7% | – |
| Beta (5Y) | 1.16 | – |
| Employees | 7,849 | 4,100 |
| StockData Score | ||
| Total score | 11 (better) | 7 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 2 | 2 |
| Dividend score | 5 (better) | 1 |
| Valuation | ||
| P/S | 0.3× (better) | 2.3× |
| P/B | 1.2× (better) | 6.1× |
| EV/EBITDA | 13.7× | – |
| P/FCF | 9.1× (better) | 49.3× |
| FCF yield | 11.0% (better) | 2.0% |
| Fair value | $34.34 | $33.30 |
| Margin of safety | 48.7% (better) | −81.8% |
| Growth | ||
| Revenue growth (TTM) | −0.73% | 9.2% (better) |
| Revenue growth, 5Y average | 3.3% | – |
| Net income growth (TTM) | −531% | −59.3% (better) |
| EPS growth (TTM) | −535% | – |
| Profitability | ||
| Gross margin | 6.7% | 30.6% (better) |
| Operating margin | −1.9% | – |
| Net margin | −3.3% | 5.1% (better) |
| FCF margin | 3.3% | 4.8% (better) |
| Return on equity | −12.2% | 8.7% (better) |
| Return on invested capital | −2.2% | – |
| Financial health | ||
| Debt / equity | 1.75 | 1.24 (better) |
| Net debt / EBITDA | 7.99 | – |
| Interest coverage | −0.7× | – |
| Current ratio | 1.45 | 1.46 (better) |
| Altman Z-score | 1.55 | 2.24 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 4.5% (better) | 0.37% |
| Buyback yield | 0.50% | – |
| Shareholder yield | 5.0% (better) | 0.37% |
| Ownership | ||
| Held by institutions | 99.8% | 84.4% |
| Held by insiders | 0.44% | 0.04% |
| Insider net buying, 12 months | −$2.5M | – |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 12.5% | 3.2% |
Go deeper
- OLN stock overview
- OLN income statement
- OLN valuation and score
- SOLS stock overview
- SOLS income statement
- SOLS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.